In magnetic drug delivery, therapeutic magnetizable particles are typically injected into the blood stream and magnets are then used to concentrate them to disease locations. The behavior of such particles in-vivo is complex and is governed by blood convection, diffusion (in blood and in tissue), extravasation, and the applied magnetic fields. Using physical first-principles and a sophisticated vessel-membrane-tissue (VMT) numerical solver, we comprehensively analyze in detail the behavior of magnetic particles in blood vessels and surrounding tissue. For any blood vessel (of any size, depth, and blood velocity) and tissue properties, particle size and applied magnetic fields, we consider a Krogh tissue cylinder geometry and solve for the resulting spatial distribution of particles. We find that there are three prototypical behaviors (blood velocity dominated, magnetic force dominated, and boundary-layer formation) and that the type of behavior observed is uniquely determined by three non-dimensional numbers (the magneticRichardson number, mass Péclet number, and Renkin reduced diffusion coefficient). Plots and equations are provided to easily read out which behavior is found under which circumstances (Figures 5,6,7,and 8). We compare our results to previously published in-vitro and in-vivo magnetic drug delivery experiments. Not only do we find excellent agreement between our predictions and prior experimental observations, but we are also able to qualitatively and quantitatively explain behavior that was previously not understood.
IntroductionMagnetic drug targeting refers to the attachment of therapeutics to magnetizable particles, and then applying magnetic fields to concentrate them to disease locations such as to solid tumors, regions of infection, or blood clots [4,[8][9][10][11][12][13][14]. Though in some cases the magnetizable particles can be introduced into the body outside the blood flow, e.g. as in magnetic treatment of the inner-ear where a small gel containing nano-particles is placed on the round window membrane [19,20], usually ferromagnetic particles are injected into a vein or artery [4][5][6][7]9,13,16,[21][22][23][24][25][26][27][28][29]. Particles so injected will circulate throughout the vasculature as the applied magnetic field is used to attempt confinement at target locations. Two main considerations arise from the in-vivo use of these particles. First, the particles must be small * Corresponding author, alek@umd.edu.Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA...